Page last updated: 2024-08-21

thiazoles and Multiple Primary Neoplasms

thiazoles has been researched along with Multiple Primary Neoplasms in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	3 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Altavilla, G; Arrigo, C; Di Mirto, C; Mondello, P; Pitini, V	1
Kameoka, Y; Kume, M; Nagao, T; Noguchi, S; Ohyagi, H; Sawada, K; Shinohara, Y; Takahashi, N	1
Ikegame, K; Kaida, K; Kato, R; Nakata, J; Ogawa, H; Okada, M; Satake, A; Tamaki, H; Yoshihara, S	1

Reviews

1 review(s) available for thiazoles and Multiple Primary Neoplasms

Article	Year
Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia. Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:22 Topics: Aged, 80 and over; Antineoplastic Agents; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 13; Dasatinib; Female; Genes, abl; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Protein Kinase Inhibitors; Pyrimidines; Thiazoles	2013

Article

Year

Dasatinib-responsive chronic lymphocytic leukemia in a patient treated for coexisting chronic myeloid leukemia.

Internal medicine (Tokyo, Japan), 2013, Volume: 52, Issue:22

Topics: Aged, 80 and over; Antineoplastic Agents; Chromosome Deletion; Chromosome Disorders; Chromosomes, Human, Pair 13; Dasatinib; Female; Genes, abl; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Neoplasms, Multiple Primary; Protein Kinase Inhibitors; Pyrimidines; Thiazoles

2013

Other Studies

2 other study(ies) available for thiazoles and Multiple Primary Neoplasms

Article	Year
Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia. Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:1 Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Dasatinib; Discoidin Domain Receptors; DNA Mutational Analysis; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Middle Aged; Mutation, Missense; Neoplasms, Multiple Primary; Pyrimidines; Radiography; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Thiazoles; Treatment Outcome	2013
Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation. Leukemia research, 2011, Volume: 35, Issue:12 Topics: Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Dasatinib; Diagnosis, Differential; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasms, Multiple Primary; Pyrimidines; Recurrence; Remission Induction; Skin Neoplasms; Thiazoles; Tumor Burden	2011

Article

Year

Response to dasatinib in a patient with SQCC of the lung harboring a discoid-receptor-2 and synchronous chronic myelogenous leukemia.

Lung cancer (Amsterdam, Netherlands), 2013, Volume: 82, Issue:1

Topics: Antineoplastic Agents; Carcinoma, Squamous Cell; Dasatinib; Discoidin Domain Receptors; DNA Mutational Analysis; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Neoplasms; Middle Aged; Mutation, Missense; Neoplasms, Multiple Primary; Pyrimidines; Radiography; Receptor Protein-Tyrosine Kinases; Receptors, Mitogen; Thiazoles; Treatment Outcome

2013

Dasatinib-induced rapid regression and complete molecular remission of multiple subcutaneous tumours presenting as relapsed chronic myeloid leukaemia after cord blood transplantation.

Leukemia research, 2011, Volume: 35, Issue:12

Topics: Antineoplastic Agents; Cord Blood Stem Cell Transplantation; Dasatinib; Diagnosis, Differential; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Neoplasms, Multiple Primary; Pyrimidines; Recurrence; Remission Induction; Skin Neoplasms; Thiazoles; Tumor Burden

2011